Mandelia Ashish Insider Trades

Insider Trading History

Track insider trading activity for Mandelia Ashish. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$276k 9,478 shares
$29.08
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$66.9k 2,300 shares
$29.08
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.67M 57,519 shares
Last Trade
Jan 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.6k 3,554 shares
$15.35
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.52M 52,388 shares
Last Trade
Jan 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.7k 1,791 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $2.18M 75,000 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 75,000 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.44M 49,396 shares
Last Trade
Jan 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$16k 1,007 shares
$15.85
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.58M 54,179 shares
Last Trade
Jan 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$75.8k 4,783 shares
$15.85
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $139k 4,783 shares
Last Trade
Jan 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$75.8k 4,783 shares
$15.85
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $154k 5,292 shares
Last Trade
Jan 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.1k 2,646 shares
$15.55
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.47M 50,403 shares
Last Trade
Jan 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.1k 2,646 shares
$15.55
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.39M 47,757 shares
Last Trade
Oct 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$170k 3,361 shares
$50.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.49M 51,118 shares
Last Trade
Oct 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$248k 4,855 shares
$51.00
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Oct 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 30,000 shares
$45.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $1.63M 55,973 shares
Last Trade
Oct 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 30,000 shares
$45.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $678k 23,328 shares
Last Trade
Jan 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$340k 5,025 shares
$67.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $2.18M 75,000 shares
Last Trade
Jan 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.66M 75,000 shares
$75.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $278k 9,566 shares
Last Trade
Jan 14, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$361k 4,783 shares
$75.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $669k 23,001 shares
Last Trade
Jan 14, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$361k 4,783 shares
$75.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $231k 7,938 shares
Last Trade
Jan 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200k 2,645 shares
$75.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vp, Chief Accounting Officer
Holding Value $530k 18,218 shares
Last Trade
Jan 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200k 2,645 shares
$75.50
$29.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up